Collaboration Details

Print  Close

Title of Collaborative Activity:

Best Pharmaceuticals for Children Act

Description of Collaborative Activity:

The Best Pharmaceuticals for Children Act (BPCA) Program is a major activity for the Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB) at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). OPPTB is responsible for developing and supporting a comprehensive national research and training effort to increase the knowledge base for understanding how to appropriately treat disease during pregnancy, infancy, and childhood using pharmaceuticals that are appropriately tested within their target populations. NICHD activities related to BPCA are intended to improve pediatric drug therapeutics through preclinical and clinical testing that lead to drug labeling changes. We are performing pediatric clinical trials in order to submit data to FDA for labeling changes. BPCA is a partnership with FDA, to a degree.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: